Chhattisgarh Clinical Trials Reimbursement
Department of Industries, Government of Chhattisgarh · Central government
Chhattisgarh's reimbursement scheme funds pharmaceutical industries up to 50% of clinical trial expenses, capped at ₹1 crore per trial across a maximum of 5 trials.
Open, rolling. Applications are accepted continuously — there is no deadline.
Key facts
- Subsidy amount
- Not specified
- Instrument
- Subsidy
- Deadline
- Rolling
- Disbursement
- Reimbursed after spend
About this scheme
Under the Chhattisgarh Industrial Development Policy 2024-30, the Reimbursement of Clinical Trials programme functions as an incentive aimed at strengthening the state's pharmaceutical sector. It addresses the high cost of running clinical trials for new drugs, therapies and medical devices by giving companies direct financial support in the form of reimbursements.
Through this support, the Government of Chhattisgarh seeks to encourage pharmaceutical industries to raise their investment in local research and development. The intended outcomes are greater innovation, more pharmaceutical manufacturing units locating in the state, high-skill employment, and a more diversified economy with greater self-reliance in healthcare infrastructure.
The programme forms part of the state's effort to establish itself as a centre for pharmaceutical innovation and production, and gives companies operating in Chhattisgarh a competitive advantage.
Who can apply
- Eligible business forms
- Private limited company, Limited liability partnership, One person company, Partnership firm, Sole proprietorship
- Udyam registration
- Not specified
- MSME registration
- Not specified
- DPIIT startup recognition
- Not specified
- GST registration
- Not specified
- Where the business may be based
- Chhattisgarh
- Available to industries in the pharmaceutical sector that carry out clinical trials in Chhattisgarh.
How to apply
- Confirm eligibility: Check that your pharmaceutical unit and clinical trials satisfy the conditions set out in the Chhattisgarh Industrial Development Policy 2024-30. - Assemble documents: Collect the expense proofs, trial approvals and company registration papers that the policy requires. - File the application: Submit it via the portal or department of the Government of Chhattisgarh named in the policy guidelines. - Wait for scrutiny: The relevant authorities will examine the application for compliance and verify the expenses. - Obtain reimbursement: Once approved, the reimbursement amount for which you qualify will be disbursed.
How applications are assessed
A committee drawn from the concerned government department, such as the Department of Industries, generally examines reimbursement applications. Its task is to confirm eligibility, verify clinical trial expenses and check that the Chhattisgarh Industrial Development Policy 2024-30 has been complied with.
Submitted documents are scrutinised during this review, and site visits or audits may be carried out to corroborate the particulars of the clinical trials conducted.
Frequently asked questions
Who is eligible for this reimbursement?
The programme targets pharmaceutical sector industries that are actively conducting clinical trials within Chhattisgarh.
What is the maximum reimbursement amount per clinical trial?
Companies can claim reimbursement of expenses incurred on each individual clinical trial, up to ₹1 crore per trial.
Is there a limit on the number of clinical trials for which a unit can claim reimbursement?
A single pharmaceutical unit may claim reimbursement for up to 5 distinct clinical trials under this policy.
What percentage of the total expenses incurred on clinical trials can be reimbursed?
The programme reimburses up to 50% of the verifiable expenses incurred on eligible clinical trials.
What is the total maximum reimbursement a single unit can receive under this scheme?
A pharmaceutical unit can claim reimbursement of up to ₹1 crore per trial, and with a maximum of 5 trials per unit, the cumulative amount can reach ₹5 crore.
Does this program apply to all types of industries in Chhattisgarh?
No. This reimbursement scheme applies only to pharmaceutical sector industries involved in clinical research and development.
Where can I find the detailed guidelines for this reimbursement?
The official Chhattisgarh Industrial Development Policy 2024-30 document contains the full guidelines for claiming this reimbursement, and it should be read in full.
Sectors
- Health Lifesciences
- Pharmaceuticals
- Clinical Trials
- Reimbursement
Details last verified on 11 November 2026. Source: the issuer's published information.